Publications
Our publications
Citation
T-helper I immunity, specific for the breast cancer antigen insulin-like growth factor-I receptor (IGF-IR), is associated with increased adiposity.
Breast Cancer Res Treatment . 2013 Jun 08 ; 139(3) 657 | DOI : 10.1007/s10549-013-2577-z
- DL. Cecil
- et al
Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025
Citation
Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancer.
Clin Cancer Res . 2013 Dec 09 ; 20(5) 1125 | DOI : 10.1158/1078-0432.CCR-13-2147
- DA. Wick
- et al
Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025
Citation
Nanoparticle-mediated combinatorial targeting of multiple human dendritic cell (DC) subsets leads to enhanced T cell activation via IL-15–dependent DC crosstalk.
J Immunol . 2014 Jul 30 ; 93(5) 2297 | DOI : 10.4049/jimmunol.1400489.
- K. Sehgal
- et al
Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025
Citation
Sterile immunity to malaria after DNA prime/adenovirus boost immunization is associated with effector memory CD8+ T cells targeting AMA1 class I epitopes.
PloS One . 2014 Sep 11 ; 9(9) e106241 | DOI : 10.1371/journal.pone.0106241.
- M. Sedegah
- et al
Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025
Citation
Memory phenotypes of HIV-specific CD8+ T cell responses are independent of functional activity as defined by cytokine output.
Open J Immunol . 2014 Sep 01 ; 4(3) 83 | DOI : 10.4236/oji.2014.43012.
- ME. Richmond
- et al
Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025
Citation
Sprouty-2 regulates HIV-specific T cell polyfunctionality.
J Clin Invest . 2014 Jan 01 ; 124(1) 198 | DOI : 10.1172/JC170510.
- YL. Chiu
- et al
Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025
Citation
Change in CD3ζ-chain expression is an independent predictor of disease status in head and neck cancer patients.
Int J Cancer . 2016 Mar 08 ; 139(1) 122 | DOI : 10.1002/ijc.30046.
- D. Upreti
- et al
Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025
Citation
Cryopreservation of Human Mucosal Leukocytes.
PLoS One . 2016 May 27 ; 11(5) e0156293 | DOI : 10.1371/journal.pone.0156293.
- SM. Hughes
Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025
Citation
Hepatitis C virus infection inhibits a Src-kinase regulatory phosphatase and reduces T cell activation in vivo.
PLoS Pathog . 2017 Feb 24 ; 13(2) e1006232 | DOI : 10.1371/journal.ppat.1006232.
- N. Bhattarai
- et al
Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025
Citation
Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer.
J Hematol Oncol . 2017 Apr 07 ; 10(1) 82 | DOI : 10.1186/s13045-017-0459-2.
- S. Mehrotra
- et al
Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025